Explore Cutting-Edge ASI Clinical Studies
A recent study published by Dr. Lui Ng and Colleagues highlights the use of digital image analysis for assessing prognostic biomarkers like CDH17 in colorectal cancer (CRC).
Detecting genetic abnormalities in cancer, crucial for diagnosis and treatment, often uses fluorescence in-situ hybridization (FISH). Automated slide scanners enhance FISH analysis by reducing microscope bottlenecks, improving accuracy, and enabling remote reviews.
This in-depth review highlights groundbreaking research in genetic studies across multiple species, utilizing both brightfield and FISH imaging techniques.
The Aided Karyotyping method significantly reduces the time needed to correct and analyze each karyogram by half.
The AON Central Lab is recognized as the first laboratory in the world to use this technology,
which decreases analysis time.
HER2 IHC scoring in new method that integrates manual interpretation with computer-aided quantitative analysis, setting a new standard in diagnostic precision.
Interoperability in digital FISH enumeration allows to use regions of interest marked by the pathologist on the H&E or IHC image when requesting FISH.
The high accuracy of the new aided karyotyping is anticipated to reduce the time spent on preparing karyograms, allowing to focus more time on chromosome analysis and reporting.
Inactivating TP53 mutations leads to a loss of function of p53, but can also often result in oncogenic gain-of-function (GOF) of mutant p53 proteins which promotes tumor development and progression.
Hexavalent chromium is a known human lung carcinogen with widespread exposure in environmental and occupational settings.